|
Protagonist Therapeutics inc (NASDAQ: PTGX) |
|
PTGX's vs. Competition, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Protagonist Therapeutics inc |
PTGX |
2,278 |
324 |
171 |
103 |
| Aadi Bioscience Inc |
AADI |
64 |
11 |
-61 |
65 |
| Adagene Inc |
ADAG |
99 |
18 |
-19 |
77 |
| Adc Therapeutics Sa |
ADCT |
178 |
123 |
-367 |
192 |
| Affimed N v |
AFMD |
0 |
9 |
-119 |
102 |
| Allakos Inc |
ALLK |
65 |
0 |
-371 |
131 |
| Alx Oncology Holdings Inc |
ALXO |
95 |
0 |
-151 |
20 |
| Adlai Nortye Ltd |
ANL |
90 |
5 |
-105 |
50 |
| Aravive Inc |
ARAV |
1 |
12 |
-30 |
31 |
| Atossa Therapeutics Inc |
ATOS |
121 |
0 |
-21 |
10 |
| Astrazeneca Plc |
AZN |
106,528 |
45,811 |
5,961 |
83,100 |
| Biomea Fusion Inc |
BMEA |
127 |
0 |
-71 |
51 |
| Bristol myers Squibb Company |
BMY |
124,995 |
46,738 |
6,692 |
34,100 |
| Bolt Biotherapeutics Inc |
BOLT |
20 |
11 |
-66 |
30 |
| Blueprint Medicines Corporation |
BPMC |
6,638 |
265 |
-718 |
582 |
| Checkpoint Therapeutics inc |
CKPT |
55 |
0 |
-54 |
22 |
| Cogent Biosciences Inc |
COGT |
814 |
8 |
-227 |
93 |
| Cytomx Therapeutics Inc |
CTMX |
55 |
40 |
-130 |
120 |
| Cytodyn inc |
CYDY |
179 |
0 |
-191 |
23 |
| Day One Biopharmaceuticals Inc |
DAWN |
1,079 |
0 |
-67 |
49 |
| Deciphera Pharmaceuticals Inc |
DCPH |
2,236 |
175 |
-190 |
355 |
| Effector Therapeutics Inc |
EFTR |
0 |
0 |
19 |
47 |
| Essa Pharma inc |
EPIX |
75 |
1 |
-35 |
24 |
| Erasca Inc |
ERAS |
233 |
0 |
-145 |
126 |
| Genprex Inc |
GNPX |
1 |
0 |
-23 |
11 |
| Gossamer Bio Inc |
GOSS |
215 |
0 |
-81 |
73 |
| G1 Therapeutics Inc |
GTHX |
305 |
28 |
-171 |
55 |
| Werewolf Therapeutics Inc |
HOWL |
40 |
21 |
-60 |
17 |
| Ideaya Biosciences Inc |
IDYA |
951 |
50 |
-53 |
65 |
| I mab |
IMAB |
205 |
4 |
-206 |
0 |
| Immunogen inc |
IMGN |
6,397 |
60 |
-125 |
346 |
| Immuneering Corporation |
IMRX |
63 |
0 |
-58 |
12 |
| Janux Therapeutics Inc |
JANX |
1,669 |
4 |
-30 |
37 |
| Kinnate Biopharma Inc |
KNTE |
117 |
0 |
-33 |
99 |
| Kura Oncology Inc |
KURA |
526 |
0 |
-135 |
89 |
| Eli Lilly And Company |
LLY |
681,890 |
29,240 |
6,033 |
43,000 |
| Lantern Pharma Inc |
LTRN |
49 |
0 |
-14 |
22 |
| Macrogenics Inc |
MGNX |
194 |
141 |
-98 |
339 |
| Mural Oncology Plc |
MURA |
67 |
0 |
-250 |
33 |
| Nucana Plc |
NCNA |
58 |
0 |
-28 |
18 |
| Nektar Therapeutics |
NKTR |
192 |
93 |
-168 |
775 |
| Nuvalent Inc |
NUVL |
5,341 |
4 |
-224 |
90 |
| Novartis Ag |
NVS |
205,372 |
46,660 |
14,854 |
109,000 |
| Northwest Biotherapeutics inc |
NWBO |
0 |
2 |
135 |
22 |
| Nextcure Inc |
NXTC |
22 |
0 |
-74 |
57 |
| Olema Pharmaceuticals Inc |
OLMA |
223 |
0 |
-100 |
45 |
| Oncosec Medical Incorporated |
ONCS |
11 |
0 |
-41 |
15 |
| Oncternal Therapeutics Inc |
ONCT |
2 |
2 |
-41 |
24 |
| Oric Pharmaceuticals Inc |
ORIC |
391 |
0 |
-91 |
74 |
| Panbela Therapeutics Inc |
PBLA |
0 |
0 |
-34 |
26 |
| Pfizer Inc |
PFE |
149,983 |
99,676 |
29,795 |
88,000 |
| Rain Oncology Inc |
RAIN |
110 |
0 |
-72 |
48 |
| Rapt Therapeutics Inc |
RAPT |
47 |
3 |
-107 |
42 |
| Regeneron Pharmaceuticals Inc |
REGN |
76,707 |
13,710 |
5,370 |
13,450 |
| Repare Therapeutics Inc |
RPTX |
53 |
69 |
-26 |
179 |
| Sagimet Biosciences inc |
SGMT |
123 |
0 |
-35 |
79 |
| Syndax Pharmaceuticals Inc |
SNDX |
849 |
140 |
-14 |
56 |
| Shattuck Labs Inc |
STTK |
47 |
6 |
-61 |
124 |
| Spyre Therapeutics Inc |
SYRE |
82 |
6 |
-85 |
36 |
| Syros Pharmaceuticals Inc |
SYRS |
2 |
23 |
-114 |
47 |
| Tg Therapeutics Inc |
TGTX |
3,946 |
7 |
-288 |
352 |
| Theseus Pharmaceuticals Inc |
THRX |
156 |
0 |
-22 |
34 |
| Tyme Technologies Inc. |
TYME |
54 |
0 |
-24 |
14 |
| Verastem Inc |
VSTM |
1,092 |
4 |
-73 |
74 |
| Xencor Inc |
XNCR |
1,199 |
297 |
30 |
280 |
| Zai Lab Limited |
ZLAB |
24,599 |
231 |
-410 |
678 |
| Zentalis Pharmaceuticals Inc |
ZNTL |
122 |
0 |
-193 |
168 |
| Agios Pharmaceuticals Inc |
AGIO |
1,868 |
31 |
-363 |
256 |
| Abvc Biopharma Inc |
ABVC |
6 |
0 |
-11 |
29 |
| Aclaris Therapeutics Inc |
ACRS |
173 |
24 |
-82 |
82 |
| Akebia Therapeutics Inc |
AKBA |
439 |
297 |
-156 |
410 |
| Allarity Therapeutics Inc |
ALLR |
0 |
24 |
-32 |
12 |
| Amgen Inc |
AMGN |
147,261 |
26,330 |
6,835 |
24,000 |
| Argenx se |
ARGX |
36,780 |
2,495 |
-295 |
700 |
| Biophytis Sa |
BPTS |
5,270 |
0 |
-19 |
20 |
| Casi Pharmaceuticals inc |
CASI |
361 |
30 |
-36 |
100 |
| Cns Pharmaceuticals Inc |
CNSP |
0 |
0 |
-2 |
11 |
| Innovation Pharmaceuticals Inc |
CTIX |
0 |
0 |
-7 |
11 |
| Cadrenal Therapeutics Inc |
CVKD |
20 |
0 |
0 |
11 |
| Gilead Sciences Inc |
GILD |
116,276 |
28,299 |
114 |
18,000 |
| Gt Biopharma Inc |
GTBP |
4 |
0 |
-11 |
23 |
| Intercept Pharmaceuticals inc |
ICPT |
603 |
354 |
-107 |
375 |
| Immuron Limited |
IMRN |
5 |
1 |
-4 |
12 |
| Incyte Corporation |
INCY |
14,181 |
4,076 |
32 |
2,524 |
| Iterum Therapeutics Plc |
ITRM |
20 |
14 |
-31 |
12 |
| Johnson and Johnson |
JNJ |
358,193 |
87,696 |
14,684 |
134,400 |
| Madrigal Pharmaceuticals Inc |
MDGL |
5,554 |
0 |
-274 |
53 |
| Mannkind Corporation |
MNKD |
1,757 |
267 |
22 |
202 |
| Medicinova Inc |
MNOV |
131 |
0 |
-10 |
13 |
| Merck and Co Inc |
MRK |
243,093 |
57,521 |
15,274 |
72,000 |
| Mirati Therapeutics Inc |
MRTX |
3,032 |
38 |
-483 |
450 |
| Myovant Sciences Ltd |
MYOV |
2,431 |
379 |
-239 |
299 |
| Novan Inc |
NOVN |
2 |
24 |
-31 |
37 |
| Organon and Co |
OGN |
4,129 |
6,409 |
1,301 |
10,000 |
| Puma Biotechnology Inc |
PBYI |
133 |
207 |
-35 |
102 |
| Pliant Therapeutics Inc |
PLRX |
395 |
10 |
-109 |
35 |
| Pulmatrix Inc |
PULM |
21 |
5 |
-22 |
14 |
| Sanofi |
SNY |
64,717 |
52,017 |
6,088 |
100,000 |
| Takeda Pharmaceutical Company Limited |
TAK |
20,292 |
29,167 |
986 |
50,000 |
| Teva Pharmaceutical Industries Limited |
TEVA |
24,299 |
15,141 |
-1,304 |
37,851 |
| Tonix Pharmaceuticals Holding Corp |
TNXP |
8 |
11 |
-98 |
43 |
| Therapeuticsmd Inc |
TXMD |
10 |
87 |
-9 |
142 |
| Vaccinex Inc |
VCNX |
2 |
-1 |
-22 |
51 |
| Verrica Pharmaceuticals Inc |
VRCA |
32 |
9 |
-28 |
41 |
| Viatris Inc |
VTRS |
13,378 |
15,049 |
-883 |
38,000 |
|
SUBTOTAL |
2,474,375 |
610,045 |
102,892 |
867,829 |
|
|
